NASDAQ:IPSC
Century Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.centurytx.comipo date
Jun 18, 2021
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lym...Show More
Earnings
Earnings Release in 18 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus